Deal Library / Pharma BD Deal Intelligence

Sun Pharmaceutical Industries Ltd. — Pharma Deals

The Pharma Closeout tracks 6 deals, $20.4B in disclosed deal value, 4 with a post-close Outcome Score for Sun Pharmaceutical Industries Ltd..

Median Critic Score: 75  ·  Median Outcome Score: 50

Best outcome: Sun Pharmaceutical Industries Ltd. / Ranbaxy Laboratories Limited (66)  ·  Weakest outcome: Sun Pharmaceutical Industries Ltd. / URL Pharma, Inc. (generics business) (34)

All 6 deals

• Sun Pharmaceutical Industries Ltd. / Ranbaxy Laboratories Limited — 2014 · $4.0B · Largely worked — most objectives met.
• Sun Pharmaceutical Industries Ltd. / Ranbaxy Laboratories Limited — 2015 · $4.0B · Mixed — partial payoff, real shortfalls.
• Sun Pharmaceutical Industries Ltd. / DUSA Pharmaceuticals, Inc. — 2012 · $230M · Mixed — partial payoff, real shortfalls.
• Sun Pharmaceutical Industries Ltd. / URL Pharma, Inc. (generics business) — 2012 · $60M · Underwhelmed — fell short of the thesis.
• Sun Pharmaceutical Industries Ltd. / Organon & Co. — 2026 · $11.8B
• Sun Pharmaceutical Industries Ltd. / Checkpoint Therapeutics, Inc. — 2025 · $355M

← Deal Library  ·  Interactive search  ·  How we score deals